Meeting Abstract

Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study


Authors listMehanna, H.; Taberna Sanz, M.; Tous, S.; Brooks, J.; von Buchwald, C.; Mena, M.; Batis, N.; Brakenhoff, R. H.; de Jong, R. Baatenburg; Klussmann, J. P.; Dalianis, T.; Mirghani, H.; Schache, A.; James, J. A.; Huang, S. H.; Broglie, M. A.; Hoffmann, M.; Alemany, L.

Publication year2020

PagesS658-S659

JournalAnnals of Oncology

Volume number31

ISSN0923-7534

eISSN1569-8041

Open access statusBronze

DOI Linkhttps://doi.org/10.1016/j.annonc.2020.08.1026

ConferenceESMO Virtual Congress

PublisherElsevier



Citation Styles

Harvard Citation styleMehanna, H., Taberna Sanz, M., Tous, S., Brooks, J., von Buchwald, C., Mena, M., et al. (2020) Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study, Annals of Oncology, 31, pp. S658-S659. https://doi.org/10.1016/j.annonc.2020.08.1026

APA Citation styleMehanna, H., Taberna Sanz, M., Tous, S., Brooks, J., von Buchwald, C., Mena, M., Batis, N., Brakenhoff, R., de Jong, R., Klussmann, J., Dalianis, T., Mirghani, H., Schache, A., James, J., Huang, S., Broglie, M., Hoffmann, M., & Alemany, L. (2020). Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study. Annals of Oncology. 31, S658-S659. https://doi.org/10.1016/j.annonc.2020.08.1026


Last updated on 2025-10-06 at 11:16